Bicara Therapeutics Inc.

BCAX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002023658

SEC filings (opens in a new tab)

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 7 sales; 171 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Bicara Therapeutics Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of BCAX: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	140	4	145	+9
Shares	57.1M	2.23M	68.9M	+14.0M (+25.5%)
Value	$960.7M	$37.5M	$1.35B	+$425.3M (+46.1%)

4 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Bicara Therapeutics Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to BCAX in Q1 2026
Institution	Shares	Value	% of portfolio
Vanguard Capital Management LLC	1,774,220	$35.3M	0.00%
Jones Hill Capital LP	1,260,136	$25.1M	5.37%
Vanguard Portfolio Management LLC	290,939	$5.79M	0.00%
Candriam Luxembourg S.C.A.	238,822	$4.75M	0.02%
Vanguard Fiduciary Trust Co	216,753	$4.31M	0.00%
Walleye Capital LLC	108,008	$2.15M	0.01%
Burkehill Global Management, LP	100,000	$1.99M	0.10%
Seven Grand Managers, LLC	62,500	$1.24M	0.08%
Martingale Asset Management L P	57,538	$1.14M	0.03%
Prudential Financial Inc	27,330	$543.6K	0.00%
Optimize Financial Inc	23,996	$477.3K	0.23%
Vanguard Asset Management, Ltd	23,943	$476.2K	0.00%
Balyasny Asset Management LLC	21,797	$433.5K	0.00%
Susquehanna Portfolio Strategies, LLC	14,017	$278.8K	0.00%
AQR Capital Management LLC	13,186	$262.3K	0.00%
Vanguard Global Advisers, LLC	12,736	$253.3K	0.00%
Squarepoint Ops LLC	10,771	$214.2K	0.00%
Thrive Wealth Management, LLC	10,344	$205.7K	0.03%
Vanguard Investments Australia, Ltd.	7,427	$147.7K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	6,400	$127.3K	0.00%
Jones Financial Companies LLLP	229	$4.21K	0.00%
Fifth Third Bancorp	170	$3.38K	0.00%
Northwestern Mutual Wealth Management Co	157	$3.12K	0.00%
Rossby Financial, LCC	111	$2.28K	0.00%
Parallel Advisors, LLC	36	$716	0.00%
Rothschild Investment LLC	30	$597	0.00%
Root Financial Partners, LLC	29	$577	0.00%
Quadrant Capital Group LLC	13	$259	0.00%
Swiss Life Asset Management Ltd	8,651	–	–

Sold out (20)

Institutions that held Bicara Therapeutics Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of BCAX in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Soleus Capital Management, L.P.	100,000	$1.68M
Jane Street Group, LLC	85,583	$1.44M
Y-Intercept (Hong Kong) Ltd	59,937	$1.01M
Dark Forest Capital Management LP	37,636	$633.4K
Trexquant Investment LP	37,094	$624.3K
XTX Topco Ltd	34,067	$573.3K
Tudor Investment Corp Et Al	27,391	$461.0K
Jump Financial, LLC	20,988	$353.2K
Brevan Howard Capital Management LP	14,117	$237.6K
Intech Investment Management LLC	14,103	$237.4K
Graham Capital Management, L.P.	13,116	$220.7K
Brinker Capital Investments, LLC	11,278	$189.8K
Aquatic Capital Management LLC	11,127	$187.3K
SG Americas Securities, LLC	11,122	$187.0K
Avanza Fonder AB	5,039	$84.8K
Simplex Trading, LLC	4,167	$70.1K
Amalgamated Bank	989	$17.0K
Daiwa Securities Group Inc.	182	$3.00K
Bellevue Asset Management, LLC	61	$1.03K
Aster Capital Management (DIFC) Ltd	1	$17

Not filed for Q1 2026 yet (4)

Institutions that held Bicara Therapeutics Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BCAX in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	2,186,150	$36.8M
Norges Bank	42,889	$721.8K
Global Retirement Partners, LLC	118	$1.99K
Comerica Bank	12	$202